Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 1/20 | 0.41 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.41 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.41 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.40 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.40 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.38 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.38 |
| ▸ | PTGFR | P43088 | 1/20 | 0.38 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2397687 | 1.00 | ADRB2 (0.41) | ADRB2ADRB1ADRB3GPR84FFAR1 | |
| SCHEMBL2382105 | 1.00 | ADRB2 (0.41) | ADRB2ADRB1ADRB3GPR84FFAR1 | |
| SCHEMBL2379282 | 1.00 | ADRB2 (0.41) | ADRB2ADRB1ADRB3GPR84FFAR1 | |
| SCHEMBL2380809 | 1.00 | ADRB2 (0.41) | ADRB2ADRB1ADRB3GPR84FFAR1 | |
| SCHEMBL2381346 | 1.00 | ADRB2 (0.41) | ADRB2ADRB1ADRB3GPR84FFAR1 | |
| SCHEMBL2380540 | 1.00 | ADRB2 (0.41) | ADRB2ADRB1ADRB3GPR84FFAR1 | |
| SCHEMBL2380577 | 1.00 | ADRB2 (0.41) | ADRB2ADRB1ADRB3GPR84FFAR1 | |
| SCHEMBL2380777 | 0.88 | EPHX2 (0.38) | ADRB2ADRB1ADRB3GPR84FFAR1 | |
| SCHEMBL2379109 | 0.87 | GPR84 (0.45) | ADRB2ADRB1ADRB3GPR84FFAR1 | |
| SCHEMBL2380579 | 0.87 | GPR84 (0.45) | ADRB2ADRB1ADRB3GPR84FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8535436-B2 | Use of cyclohexane polycarboxylic acid derivatives for removing dust from chemical construction products | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2013-09-17 | — | — | US | disclosed |
| US-20110232825-A1 | CYCLOHEXANE POLYCARBOXYLIC ACID DERIVATIVES AS PLASTICIZERS FOR ADHESIVES AND SEALANTS | BASF SE (DE) | 2011-09-29 | — | — | US | disclosed |
| US-20110209644-A1 | Use of Cyclohexane Polycarboxylic Acid Derivatives For Removing Dust From Chemical Construction Products | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2011-09-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110209644-A1 | Use of Cyclohexane Polycarboxylic Acid Derivatives For Removing Dust From Chemical Construction Products | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, HPD, HCAR2 | ADRB2 4247/4885ADRB1 4208/4885ADRB3 4455/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.